Venrock Adviser, LLC

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1615982 NEW YORK, NY

Position in RLMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$47,362,590

+$13,652,666 QoQ

Shares Held

6,844,305

+41.3% QoQ

Ownership

6.42%

of shares outstanding

% of Portfolio

1.44%

of 13F equity value

Holder Rank

of 126 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names. RLMD ranks #15 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	8,493,321	$1,127,318,496
2	ORKA	Oruka Therapeutics, Inc.	4,148,428	$394,805,892
3	ERAS	Erasca, Inc.	17,891,812	$327,777,995
4	SYRE	Spyre Therapeutics, Inc.	2,985,448	$265,048,073
5	DNTH	Dianthus Therapeutics, Inc. /DE/	1,180,000	$115,026,400
6	OCUL	Ocular Therapeutix, Inc	10,346,926	$101,606,813
7	DMRA	Damora Therapeutics, Inc.	3,603,595	$93,729,505
8	SVRA	Savara Inc	14,745,943	$90,835,008

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$47,362,590	6,844,305	+41.3%	Shares	Sole	2026-08-14
2026-03-31	$33,709,924	4,843,380	+219.1%	Shares	Sole	2026-05-15
2022-09-30	$56,198,433	1,518,056	-33.1%	Shares	Sole	2023-05-15
2022-06-30	$43,108,667	2,270,072	0.0%	Shares	Sole	2023-05-15
2022-03-31	$61,269,243	2,270,072	0.0%	Shares	Sole	2022-05-16
2021-12-31	$51,144,722	2,270,072	+63.6%	Shares	Sole	2022-02-14
2021-09-30	$36,372,141	1,387,720	0.0%	Shares	Sole	2021-11-15
2021-06-30	$44,420,917	1,387,720	+62.6%	Shares	Sole	2021-08-13
2021-03-31	$30,041,383	853,206	+27.6%	Shares	Sole	2021-05-14
2020-12-31	$21,436,870	668,440	0.0%	Shares	Sole	2021-02-12
2020-09-30	$25,146,712	668,440	0.0%	Shares	Sole	2020-11-16
2020-06-30	$29,912,690	668,440	-20.7%	Shares	Sole	2020-08-14
2020-03-31	$28,748,385	842,814	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.